vs
PTC THERAPEUTICS, INC.（PTCT）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
BRC Group Holdings, Inc.的季度营收约是PTC THERAPEUTICS, INC.的1.1倍（$188.3M vs $164.7M），BRC Group Holdings, Inc.净利率更高（47.9% vs -82.0%，领先129.9%），BRC Group Holdings, Inc.同比增速更快（-21.9% vs -22.7%），过去两年PTC THERAPEUTICS, INC.的营收复合增速更高（-11.5% vs -15.4%）
PTC Therapeutics是一家总部位于美国的制药企业，专注于开发口服小分子药物及基因疗法，通过靶向转录后调控机制调节基因表达，相关产品管线主要面向罕见病治疗领域，致力于满足相关疾病未被覆盖的临床治疗需求。
PTCT vs RILY — 直观对比
营收规模更大
RILY
是对方的1.1倍
$164.7M
营收增速更快
RILY
高出0.9%
-22.7%
净利率更高
RILY
高出129.9%
-82.0%
两年增速更快
PTCT
近两年复合增速
-15.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $164.7M | $188.3M |
| 净利润 | $-135.0M | $90.3M |
| 毛利率 | — | 79.5% |
| 营业利润率 | -43.3% | 32.3% |
| 净利率 | -82.0% | 47.9% |
| 营收同比 | -22.7% | -21.9% |
| 净利润同比 | -104.8% | 1710.8% |
| 每股收益（稀释后） | $-1.63 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PTCTRILY
| Q4 25 | $164.7M | $188.3M | ||
| Q3 25 | $211.0M | $215.3M | ||
| Q2 25 | $178.9M | $188.2M | ||
| Q1 25 | $1.2B | $197.2M | ||
| Q4 24 | $213.2M | $241.0M | ||
| Q3 24 | $196.8M | $225.5M | ||
| Q2 24 | $186.7M | $256.0M | ||
| Q1 24 | $210.1M | $263.4M |
净利润PTCTRILY
| Q4 25 | $-135.0M | $90.3M | ||
| Q3 25 | $15.9M | $91.1M | ||
| Q2 25 | $-64.8M | $139.5M | ||
| Q1 25 | $866.6M | $-10.0M | ||
| Q4 24 | $-65.9M | $-5.6M | ||
| Q3 24 | $-106.7M | $-284.4M | ||
| Q2 24 | $-99.2M | $-433.6M | ||
| Q1 24 | $-91.6M | $-49.2M |
毛利率PTCTRILY
| Q4 25 | — | 79.5% | ||
| Q3 25 | — | 83.7% | ||
| Q2 25 | — | 81.3% | ||
| Q1 25 | — | 81.4% | ||
| Q4 24 | — | 79.8% | ||
| Q3 24 | — | 82.1% | ||
| Q2 24 | — | 84.5% | ||
| Q1 24 | — | 85.3% |
营业利润率PTCTRILY
| Q4 25 | -43.3% | 32.3% | ||
| Q3 25 | 1.4% | 30.4% | ||
| Q2 25 | -19.5% | 5.7% | ||
| Q1 25 | 82.5% | -31.2% | ||
| Q4 24 | -76.2% | -69.2% | ||
| Q3 24 | -27.7% | -36.4% | ||
| Q2 24 | -21.5% | -90.8% | ||
| Q1 24 | -21.6% | -6.1% |
净利率PTCTRILY
| Q4 25 | -82.0% | 47.9% | ||
| Q3 25 | 7.5% | 42.3% | ||
| Q2 25 | -36.3% | 74.1% | ||
| Q1 25 | 73.7% | -5.1% | ||
| Q4 24 | -30.9% | -2.3% | ||
| Q3 24 | -54.2% | -126.1% | ||
| Q2 24 | -53.1% | -169.4% | ||
| Q1 24 | -43.6% | -18.7% |
每股收益（稀释后）PTCTRILY
| Q4 25 | $-1.63 | $2.78 | ||
| Q3 25 | $0.20 | $2.91 | ||
| Q2 25 | $-0.83 | $4.50 | ||
| Q1 25 | $10.04 | $-0.39 | ||
| Q4 24 | $-0.85 | $-0.01 | ||
| Q3 24 | $-1.39 | $-9.39 | ||
| Q2 24 | $-1.29 | $-14.35 | ||
| Q1 24 | $-1.20 | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.9B | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $-205.3M | $-171.5M |
| 总资产 | $2.9B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PTCTRILY
| Q4 25 | $1.9B | $226.6M | ||
| Q3 25 | $1.7B | $184.2M | ||
| Q2 25 | $2.0B | $267.4M | ||
| Q1 25 | $2.0B | $138.3M | ||
| Q4 24 | $1.1B | $146.9M | ||
| Q3 24 | $1.0B | $159.2M | ||
| Q2 24 | $1.1B | $236.9M | ||
| Q1 24 | $884.8M | $190.7M |
总债务PTCTRILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PTCTRILY
| Q4 25 | $-205.3M | $-171.5M | ||
| Q3 25 | $-155.8M | $-260.5M | ||
| Q2 25 | $-206.5M | $-351.7M | ||
| Q1 25 | $-185.8M | $-496.8M | ||
| Q4 24 | $-1.1B | $-488.2M | ||
| Q3 24 | $-1.1B | $-497.6M | ||
| Q2 24 | $-980.2M | $-218.3M | ||
| Q1 24 | $-893.9M | $228.4M |
总资产PTCTRILY
| Q4 25 | $2.9B | $1.7B | ||
| Q3 25 | $2.6B | $1.7B | ||
| Q2 25 | $2.6B | $1.5B | ||
| Q1 25 | $2.7B | $1.5B | ||
| Q4 24 | $1.7B | $1.8B | ||
| Q3 24 | $1.8B | $2.2B | ||
| Q2 24 | $1.9B | $3.2B | ||
| Q1 24 | $1.8B | $5.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-34.3M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $-36.6M | — |
| 自由现金流率自由现金流/营收 | -22.3% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | 0.29× |
| 过去12个月自由现金流最近4个季度 | $702.3M | — |
8季度趋势，按日历期对齐
经营现金流PTCTRILY
| Q4 25 | $-34.3M | $26.2M | ||
| Q3 25 | $-66.3M | $-60.6M | ||
| Q2 25 | $-58.3M | $-25.6M | ||
| Q1 25 | $870.1M | $184.0K | ||
| Q4 24 | $-30.0M | $-2.7M | ||
| Q3 24 | $-77.0M | $19.5M | ||
| Q2 24 | $-71.5M | $111.5M | ||
| Q1 24 | $70.8M | $135.4M |
自由现金流PTCTRILY
| Q4 25 | $-36.6M | — | ||
| Q3 25 | $-69.7M | — | ||
| Q2 25 | $-59.6M | — | ||
| Q1 25 | $868.4M | — | ||
| Q4 24 | $-33.8M | — | ||
| Q3 24 | $-77.5M | — | ||
| Q2 24 | $-78.8M | — | ||
| Q1 24 | $61.2M | — |
自由现金流率PTCTRILY
| Q4 25 | -22.3% | — | ||
| Q3 25 | -33.1% | — | ||
| Q2 25 | -33.3% | — | ||
| Q1 25 | 73.8% | — | ||
| Q4 24 | -15.8% | — | ||
| Q3 24 | -39.4% | — | ||
| Q2 24 | -42.2% | — | ||
| Q1 24 | 29.1% | — |
资本支出强度PTCTRILY
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 4.0% | — | ||
| Q1 24 | 4.6% | — |
现金转化率PTCTRILY
| Q4 25 | — | 0.29× | ||
| Q3 25 | -4.17× | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | 1.00× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PTCT
暂无分部数据
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
